We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
NVOS | Novo Integrated Sciences Inc | 1.05 | 0.599 | 132.82% | 310,284,633 |
BNAI | Brand Engagement Network Inc | 5.4799 | 2.90 | 112.40% | 67,994,392 |
PRTG | Portage Biotech Inc | 0.51 | 0.253 | 98.44% | 4,260,166 |
PLTNU | Plutoniam Acquisition Corporation | 12.06 | 5.42 | 81.63% | 1,810 |
PEGRU | Project Energy Reimagined Acquisition Corporation | 11.43 | 3.08 | 36.89% | 1,191 |
SLNA | Selina Hospitality PLC | 0.0945 | 0.0226 | 31.43% | 113,414,895 |
CYCC | Cyclacel Pharmaceuticals Inc | 2.6399 | 0.6199 | 30.69% | 2,367,157 |
VCNX | Vaccinex Inc | 6.78 | 1.58 | 30.38% | 454,991 |
GNPX | Genprex Inc | 3.14 | 0.72 | 29.75% | 3,384,633 |
XCUR | Exicure Inc | 0.4501 | 0.0991 | 28.23% | 341,223 |
DRRX | Durect Corp | 1.73 | 0.38 | 28.15% | 565,903 |
As previously reported, the Board of Directors (the “Board”) of Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) approved the repurchase of up to $5 million of the Company’s outstanding common stock from time to time in the open market at prevailing market prices or in privately negotiated transactions (the “Stock Repurchase Program”). The Company today announced that the Board is conducting a strategic review to determine whether it is appropriate to increase the maximum amount that can be repurchased pursuant to the Stock Repurchase Program based on the amount, if any, of excess funds that may be ...
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) announced that the Journal of the American Medical Association (JAMA) published a manuscript titled, “Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer with EGFR Variant: A Randomized Clinical Trial.” The publication is based on the results of HARMONi-A, a single region, multi-center, Phase III study conducted in China sponsored by Akeso, Inc. (Akeso, HKEX Code: 9926.HK), with data generated and analyzed by Akeso.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
FNMA | Fannie Mae-No Politics | 44 | |
RSPI | RespireRx Pharmaceuticals Inc | 29 | |
SPZI | SPOOZ Inc | 76 | |
4 | ELTP | Elite Pharmaceuticals Inc | 14 |
5 | RONN | Ronn Motor Group Inc | 18 |
6 | CYDY | Cytodyn Inc | 12 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 68,374.60 | 626.19 | 0.92% | 1.34T | 2,204,530,385 |
ETH | Ethereum | 3,803.21 | 23.35 | 0.62% | 456.04B | 1,412,981,965 |
USDT | Tether USD | 0.99941 | -0.00005 | -0.01% | 97.79B | 81,925,557 |
BNB | Binance Coin | 609.34 | 6.72 | 1.11% | 96.11B | 170,383,918 |
SOL | Solana | 162.88 | -0.180 | -0.11% | 71.76B | 593,659,941 |
STETH | stETH | 3,801.14 | 23.55 | 0.62% | 37.19B | 4,622,757 |
XRP | Ripple | 0.5164 | 0.003 | 0.58% | 28.11B | 131,040,409 |
USDC | USD Coin | 0.99998 | 0.00008 | 0.01% | 28.07B | 350,568,098 |
TONCOIN | Wrapped TON Coin | 6.81 | -0.002052 | -0.03% | 24.42B | 220,139,278 |
DOGE | Dogecoin | 0.15907 | 0.00191 | 1.22% | 22.77B | 197,314,403 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions